GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.

MCQs and case studies manageable, numericals slightly tricky and time-consuming; students now await unofficial answer keys for Set 2 and Set 3 ...

Becoming a millionaire is a goal for many people. Once you reach that milestone, however, it can be hard to maintain that ...

Gov. Whitmer address and recent poll reveal new challenges for Michigan. Here are some ways to recapture our mojo.

Good day, and welcome to the Gold Royalty Corp. Fourth Quarter 2025 Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

From the WWII epic Masters of the Air to the critically acclaimed thriller Black Bird, these miniseries are the best of what ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

Ineffective retention strategies can lead to employee turnover. Private childcare business owners who struggle to improve employee retention may find their business confronting attrition as a result.

On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric ...